Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 2
1989 1
1990 1
1991 1
1992 2
1995 2
1996 1
1997 3
1998 5
1999 1
2000 1
2001 1
2002 1
2003 1
2004 4
2005 1
2006 2
2008 3
2010 3
2011 2
2012 3
2013 4
2014 1
2015 4
2016 2
2017 3
2018 2
2020 2
2021 6
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

66 results
Results by year
Filters applied: . Clear all
Page 1
Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease.
Jonasch E, Donskov F, Iliopoulos O, Rathmell WK, Narayan VK, Maughan BL, Oudard S, Else T, Maranchie JK, Welsh SJ, Thamake S, Park EK, Perini RF, Linehan WM, Srinivasan R; MK-6482-004 Investigators. Jonasch E, et al. Among authors: iliopoulos o. N Engl J Med. 2021 Nov 25;385(22):2036-2046. doi: 10.1056/NEJMoa2103425. N Engl J Med. 2021. PMID: 34818478 Clinical Trial.
NNT mediates redox-dependent pigmentation via a UVB- and MITF-independent mechanism.
Allouche J, Rachmin I, Adhikari K, Pardo LM, Lee JH, McConnell AM, Kato S, Fan S, Kawakami A, Suita Y, Wakamatsu K, Igras V, Zhang J, Navarro PP, Lugo CM, Noonan HR, Christie KA, Itin K, Mujahid N, Lo JA, Won CH, Evans CL, Weng QY, Wang H, Osseiran S, Lovas A, Németh I, Cozzio A, Navarini AA, Hsiao JJ, Nguyen N, Kemény LV, Iliopoulos O, Berking C, Ruzicka T, Gonzalez-José R, Bortolini MC, Canizales-Quinteros S, Acuna-Alonso V, Gallo C, Poletti G, Bedoya G, Rothhammer F, Ito S, Schiaffino MV, Chao LH, Kleinstiver BP, Tishkoff S, Zon LI, Nijsten T, Ruiz-Linares A, Fisher DE, Roider E. Allouche J, et al. Among authors: iliopoulos o. Cell. 2021 Aug 5;184(16):4268-4283.e20. doi: 10.1016/j.cell.2021.06.022. Epub 2021 Jul 6. Cell. 2021. PMID: 34233163
The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha.
Zhong L, D'Urso A, Toiber D, Sebastian C, Henry RE, Vadysirisack DD, Guimaraes A, Marinelli B, Wikstrom JD, Nir T, Clish CB, Vaitheesvaran B, Iliopoulos O, Kurland I, Dor Y, Weissleder R, Shirihai OS, Ellisen LW, Espinosa JM, Mostoslavsky R. Zhong L, et al. Among authors: iliopoulos o. Cell. 2010 Jan 22;140(2):280-93. doi: 10.1016/j.cell.2009.12.041. Cell. 2010. PMID: 20141841 Free PMC article.
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia.
Metallo CM, Gameiro PA, Bell EL, Mattaini KR, Yang J, Hiller K, Jewell CM, Johnson ZR, Irvine DJ, Guarente L, Kelleher JK, Vander Heiden MG, Iliopoulos O, Stephanopoulos G. Metallo CM, et al. Among authors: iliopoulos o. Nature. 2011 Nov 20;481(7381):380-4. doi: 10.1038/nature10602. Nature. 2011. PMID: 22101433 Free PMC article.
HIF2a inhibitors for the treatment of VHL disease.
Metelo AM, Noonan H, Iliopoulos O. Metelo AM, et al. Among authors: iliopoulos o. Oncotarget. 2015 Sep 15;6(27):23036-7. doi: 10.18632/oncotarget.4564. Oncotarget. 2015. PMID: 26325097 Free PMC article. Review. No abstract available.
Evaluation, diagnosis and surveillance of renal masses in the setting of VHL disease.
Chahoud J, McGettigan M, Parikh N, Boris RS, Iliopoulos O, Rathmell WK, Daniels AB, Jonasch E, Spiess PE; International VHL Surveillance Guidelines Consortium-Renal Committee. Chahoud J, et al. Among authors: iliopoulos o. World J Urol. 2021 Jul;39(7):2409-2415. doi: 10.1007/s00345-020-03441-3. Epub 2020 Sep 16. World J Urol. 2021. PMID: 32936333 Free PMC article. Review.
Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement.
Bratslavsky G, Mendhiratta N, Daneshvar M, Brugarolas J, Ball MW, Metwalli A, Nathanson KL, Pierorazio PM, Boris RS, Singer EA, Carlo MI, Daly MB, Henske EP, Hyatt C, Middleton L, Morris G, Jeong A, Narayan V, Rathmell WK, Vaishampayan U, Lee BH, Battle D, Hall MJ, Hafez K, Jewett MAS, Karamboulas C, Pal SK, Hakimi AA, Kutikov A, Iliopoulos O, Linehan WM, Jonasch E, Srinivasan R, Shuch B. Bratslavsky G, et al. Among authors: iliopoulos o. Cancer. 2021 Nov 1;127(21):3957-3966. doi: 10.1002/cncr.33679. Epub 2021 Aug 3. Cancer. 2021. PMID: 34343338
Differential substrate use in EGF- and oncogenic KRAS-stimulated human mammary epithelial cells.
Keibler MA, Dong W, Korthauer KD, Hosios AM, Moon SJ, Sullivan LB, Liu N, Abbott KL, Arevalo OD, Ho K, Lee J, Phanse AS, Kelleher JK, Iliopoulos O, Coloff JL, Vander Heiden MG, Stephanopoulos G. Keibler MA, et al. Among authors: iliopoulos o. FEBS J. 2021 Oct;288(19):5629-5649. doi: 10.1111/febs.15858. Epub 2021 May 13. FEBS J. 2021. PMID: 33811729 Free PMC article.
How many pathways to pheochromocytoma?
Neumann HP, Hoegerle S, Manz T, Brenner K, Iliopoulos O. Neumann HP, et al. Among authors: iliopoulos o. Semin Nephrol. 2002 Mar;22(2):89-99. doi: 10.1053/snep.2002.30207. Semin Nephrol. 2002. PMID: 11891502 Review.
The fission yeast FLCN/FNIP complex augments TORC1 repression or activation in response to amino acid (AA) availability.
Calvo IA, Sharma S, Paulo JA, Gulka AOD, Boeszoermenyi A, Zhang J, Lombana JM, Palmieri CM, Laviolette LA, Arthanari H, Iliopoulos O, Gygi SP, Motamedi M. Calvo IA, et al. Among authors: iliopoulos o. iScience. 2021 Oct 23;24(11):103338. doi: 10.1016/j.isci.2021.103338. eCollection 2021 Nov 19. iScience. 2021. PMID: 34805795 Free PMC article.
66 results